HB
Therapeutic Areas
DeBogy Molecular Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Antimicrobial Surface Modification Platform | Prevention of microbial contamination and healthcare-associated infections (HAIs) | Pre-clinical |
Leadership Team at DeBogy Molecular
WG
Wayne Gattinella
Chief Executive Officer
SD
Stephane Delaunay
Co-Founder, Corporate Strategy
EG
Emmanuel Gibon
Co-Founder, VP Research & Academic Partnerships
JY
James Yue
Chief Medical Director
OB
Othman Bouloussa
Co-Founder, VP Chemical Research
ZD
Zoe Durand
Co-Founder, Marketing
DC
Damon Campolo
Chief Revenue Officer